Home / Resources (page 939)

Resources

RESOURCES

Novartis receives FDA approval for Valturna®

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure. Valturna combines in a single pill valsartan, an angiotensin receptor blocker, with aliskiren, the only approved direct renin inhibitor. Valturna is the first therapy to target two points within the renin angiotensin …

Read More »